What’s Left In $400M Skinny Label Row? A Lot, Court Says – Law360
What’s Left In $400M Skinny Label Row? A Lot, Court Says Law360
In: PATENT NEWS
What’s Left In $400M Skinny Label Row? A Lot, Court Says Law360
In: PATENT NEWS
The claims require steady state blood levels, which Oracea achieves through some doxycycline released right away (IR) and some released later (DR).
In: The IPKat BLOG
http://ipkitten.blogspot.com/2024/12/new-french-draft-law-on-ai-generated-or.html The subject of AI is pervasive to such an extent that it is impossible to avoid its influence [latest developments here , here, here or here]. Readers may recall that this Kat reported on the existence of a lacklustre draft law aimed at establishing a French copyright framework for... Continue reading
In: PATENT NEWS
The bill would limit the number of patents a biologic drug manufacturer can use in patent disputes, which can block biosimilar competitors from …
In: PATENT NEWS
PVM’s first allegation of anticompetitive conduct was that PPC sat on its rights and only complained about patent infringement after a PPC customer …
In: PATENT NEWS
Wash.: Summary judgment granted in fiber optic patent inventorship dispute, (Dec 12, 2024). Law Firms Mentioned:Faegre Drinker Biddle & Reath LLP …
In: PATENT NEWS
The bill would limit the number of patents a biologic drug manufacturer can use in patent disputes, which can block biosimilar competitors from …
In: PATENT NEWS
Samsung, Techiya Settle Second Patent Suit Over Galaxy Products Bloomberg Law
In: PATENT NEWS
Although legal, the timing of the transactions, during a global health crisis, drew criticism. Patent disputes and legal battles. Arbutus Biopharma ( …
In: PATENT NEWS
The Federal Circuit clarifies the pre-AIA on-sale bar, ruling a quotation letter can invalidate a patent. Geographic scope of the bar depends on …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION